Introduction
Retinopathy of prematurity is a disorder of retinal blood vessel development that affects premature infants. It begins in the eye, specifically in the retina, the light-sensitive tissue at the back of the eye that converts visual input into signals the brain can interpret. The condition arises because retinal blood vessels normally finish developing late in fetal life, and when birth occurs too early, that development is interrupted. After premature delivery, changes in oxygen exposure and growth signaling can cause the retinal vessels to grow in an abnormal pattern, sometimes producing fragile vessels and scar-related changes that distort the retina.
The defining biological feature of retinopathy of prematurity is abnormal vascular development, not a primary defect in the retina as a sensory tissue. The disorder reflects a mismatch between the retina’s metabolic needs and the immature vascular system that supplies it. Understanding how the retinal circulation normally forms, and how premature birth alters that process, explains why this condition occurs.
The Body Structures or Systems Involved
The main structure involved is the retina, a thin layered tissue lining the inner surface of the back of the eye. The retina contains photoreceptors, bipolar cells, ganglion cells, and supporting glial cells. These cells work together to detect light and transmit visual information through the optic nerve to the brain. Because the retina has high metabolic demand, it requires a precise network of blood vessels to deliver oxygen and nutrients.
In normal fetal development, the retinal blood vessels grow outward from the optic nerve toward the periphery of the retina. This process is guided by local signals from retinal tissues, especially gradients of oxygen and growth factors such as vascular endothelial growth factor, or VEGF. VEGF helps direct new vessel formation where oxygen supply is insufficient. Other molecules, including insulin-like growth factor 1 and several developmental signaling pathways, support orderly vascular growth and vessel stabilization.
The disorder also involves the systemic physiology of the premature infant, especially oxygen regulation, lung function, and overall circulatory stability. Before birth, the fetus develops in a relatively low-oxygen environment. After birth, oxygen levels rise abruptly, and premature infants often need supplemental oxygen because their lungs are not fully mature. These oxygen changes influence the retinal environment and alter the signals that control vessel growth.
How the Condition Develops
Retinopathy of prematurity develops in two broad phases. The first phase begins soon after premature birth. In utero, the retina is still partly avascular, meaning some peripheral regions have not yet been reached by blood vessels. Normally, the low-oxygen state of these regions stimulates controlled vessel growth. After birth, especially if oxygen exposure is relatively high, that hypoxic signal is reduced. The immature retina then receives less of the stimulus that normally drives vessel formation, and existing vessels may stop growing or even regress.
This early suppression of vascular growth leaves the peripheral retina underperfused and metabolically stressed. The tissue becomes increasingly hypoxic as the retina matures and its oxygen needs increase. When oxygen demand outpaces supply, the retina responds by sharply increasing production of angiogenic factors, especially VEGF. This marks the second phase of disease. Instead of producing slow, organized vessel extension, the retina can generate excessive and disordered vessel growth at the interface between vascular and avascular tissue.
The resulting vessels are abnormal because they grow in a distorted pattern and may extend into areas where they do not belong, including the vitreous side of the retina. They are often structurally fragile and poorly regulated. The process is not simply one of more vessels forming; it is a failure of developmental control. The balance between oxygen, growth factor expression, and vessel maturation has been disrupted during a critical developmental window, leading to pathological angiogenesis.
In some infants, the disease does not progress beyond this vascular abnormality and later regresses as retinal maturation catches up. In others, the abnormal vessels are followed by fibrous tissue formation. Scar-like tissue can contract and pull on the retina, creating traction. This is a later consequence of the same dysregulated repair process, where angiogenic signals and fibrocellular proliferation interact.
Structural or Functional Changes Caused by the Condition
The most direct change in retinopathy of prematurity is incomplete or abnormal vascularization of the peripheral retina. Areas that should have a mature capillary network remain underdeveloped, while other regions develop abnormal vessels that do not follow the normal retinal architecture. This uneven pattern changes the way oxygen and nutrients are delivered across the retina.
When vessel growth is interrupted, the retina may remain metabolically vulnerable. The tissue can experience chronic relative hypoxia, which perpetuates abnormal signaling. As the disease advances, fragile new vessels may extend into the vitreous and can leak fluid or blood. The surrounding retinal tissue may become distorted by the presence of abnormal vascular and fibrous proliferation.
Fibrovascular tissue can also remodel the eye’s internal structure. If contraction occurs, it can exert traction on the retina, altering its shape and position. This mechanical distortion is a consequence of scar-like tissue forming in a space where the retina should remain thin and smoothly apposed to the underlying layers. In severe cases, this can threaten retinal attachment and interfere with normal image formation.
Functionally, the retina may no longer maintain the stable vascular support required for normal visual development. Even when the anatomy appears to improve, earlier disruption of retinal blood vessel development can leave behind altered retinal maturation. Because visual pathways are developing rapidly in infancy, structural disturbance during this period can affect later visual function.
Factors That Influence the Development of the Condition
The strongest factor in retinopathy of prematurity is premature birth, especially birth at a very early gestational age. The earlier the delivery, the less complete the retinal vascular network at the time of birth. Extremely premature infants therefore begin life with a retina that is still dependent on developmental signals that would normally occur in the womb.
Oxygen exposure is a major environmental influence because retinal vessel growth is tightly regulated by oxygen-sensitive signaling. Both excessive oxygen and large swings in oxygen levels can disturb the normal balance of vessel formation. Supplemental oxygen can be life-saving for an infant with immature lungs, but the retinal vasculature is sensitive to the oxygen environment, particularly during the period when vessels are still forming.
Overall illness severity also matters. Infants with unstable respiration, poor growth, infection, or inflammatory stress may have altered regulation of factors involved in vascular development. Insulin-like growth factor 1, which is normally supplied in part by the placenta before birth, may be lower after preterm delivery and can affect normal vascular growth. Inflammatory mediators and oxidative stress can further disrupt endothelial cell behavior and vessel maturation.
Genetic background likely influences susceptibility, although no single gene explains most cases. Variations in how an infant responds to oxygen, inflammation, and developmental signaling may affect the risk and severity of disease. The condition therefore reflects an interaction between developmental immaturity and postnatal physiologic stress rather than a single isolated cause.
Variations or Forms of the Condition
Retinopathy of prematurity ranges from mild disease with limited vascular disturbance to severe disease with marked abnormal vessel growth and tractional changes. Mild forms may involve a small area of the peripheral retina and may stabilize or regress as the infant matures. In these cases, the underlying pattern is one of temporary delay in normal vascular development with limited secondary angiogenic response.
More severe forms arise when a larger portion of the retina remains avascular or when the hypoxia-driven response is especially intense. These cases are more likely to show prominent abnormal vessel proliferation at the junction between vascular and avascular retina. The greater the imbalance between metabolic need and vascular supply, the stronger the drive toward disorganized angiogenesis.
The disease can also be described by its pattern of activity. Some cases are predominantly ischemic, meaning underperfusion and oxygen deprivation drive the process. Others develop a more aggressive fibrovascular response, where scar formation becomes more prominent. These patterns are linked because ischemia stimulates angiogenic signaling, and prolonged abnormal angiogenesis can trigger fibrous remodeling.
Another useful distinction is whether the disease remains confined to the retinal periphery or progresses toward the posterior retina and structural distortion. Disease that stays peripheral reflects limited disruption of developmental vessel growth. Disease that extends centrally or produces traction reflects more extensive breakdown in the normal organization of retinal vascular maturation.
How the Condition Affects the Body Over Time
Over time, retinopathy of prematurity may follow several biological paths. In some infants, vascular growth slows, matures, and becomes more organized as oxygen and growth factor conditions normalize. The retina then gains a more stable circulation, and the abnormal phase of disease resolves. This outcome reflects developmental catch-up rather than reversal of a completely formed injury.
In other cases, the abnormal vessel response persists long enough to produce structural remodeling. Persistent hypoxia can maintain elevated angiogenic signaling, and the resulting vessels may remain immature and unstable. Fibrous tissue can accumulate alongside these vessels, and contraction of this tissue can reshape the internal architecture of the eye. The longer this process continues, the greater the chance of lasting distortion of retinal structure.
The long-term consequences depend on how much of the retina was affected and whether traction or detachment developed. Even when severe structural complications do not occur, early disruption of vascular development can leave the retina less uniformly supplied and can alter the conditions under which visual pathways mature. Because the visual system develops in infancy, the timing of the insult matters as much as its severity.
The body’s response to the condition is therefore developmental and adaptive at first, but potentially maladaptive when signaling remains abnormal. The same molecules that normally support healthy vessel growth can, under disrupted conditions, drive pathological vascular proliferation and scar formation. Retinopathy of prematurity is best understood as a disease of mis-timed development in a tissue that depends on precise vascular maturation.
Conclusion
Retinopathy of prematurity is an eye disorder caused by disrupted development of the retinal blood vessels in premature infants. It involves the retina, its vascular supply, and the oxygen-sensitive signaling pathways that regulate vessel growth. The condition begins when premature birth interrupts normal in utero vascular development and is then shaped by postnatal oxygen exposure, growth factor imbalance, and retinal hypoxia.
Its defining feature is not simply abnormal blood vessel growth, but abnormal vessel growth occurring at the wrong time and in the wrong pattern during a critical developmental stage. This can lead to incomplete vascularization, fragile new vessels, fibrous remodeling, and in severe cases traction on the retina. Understanding these biological and physiological mechanisms provides the framework for understanding why the condition arises and how it alters the eye.